Evidence map›Paper›PMID 35744627›Full record

ArticleMicroorganisms2022

Meng Zhou, Zishu Liu, Jiaqi Wang, Yuxiang Zhao, Baolan Hu

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Continuous Cropping ofLife (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Co-inoculation of antagonisticFrontiers in microbiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Meng ZhouDepartment of Environmental Engineering, College of Environmental & Resources Sciences, Zhejiang University, Hangzhou 310058, China.
Zishu LiuDepartment of Environmental Engineering, College of Environmental & Resources Sciences, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0001-6820-4593
Jiaqi WangDepartment of Environmental Engineering, College of Environmental & Resources Sciences, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0001-5092-3485
Yuxiang ZhaoDepartment of Environmental Engineering, College of Environmental & Resources Sciences, Zhejiang University, Hangzhou 310058, China.
Baolan HuDepartment of Environmental Engineering, College of Environmental & Resources Sciences, Zhejiang University, Hangzhou 310058, China.
Zhejiang University · CN

Funding

National Key Research and Development Program of China [2018YFC1800702]
6 · The paper itself

Abstract

Polycyclic aromatic hydrocarbons (PAHs) are organic pollutants widely present in industrial sites. Microbial degradation is an effective method of removing PAHs. The identification of microorganisms that have important ecological functions at the site is of great significance for PAH removal. We collected soil samples at three depths in the range of 0-100 cm at 70-day intervals at the coking site and explored the degradation of PAHs. We combined molecular ecology networking, metagenomics, and genome assembly to search for microorganisms that persist, dominate, and affect the microbial community construction in the degradation process and analyzed their adaptation strategies. The results showed that 15.78 mg/kg of PAHs naturally decayed, and 13.33 mg/kg of PAHs migrated from 30-100 cm to 0-30 cm in the soil.

Indexed as

metagenomicsmicroorganismsPAH degradationsoilSphingomonas

Identifiers

PMID35744627
PMCPMC9229013
OpenAlexW4281621728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.